Pharmaceuticals, Biotechnology and Life Sciences
BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) will host a conference call and webcast discussion regarding the positive topline results from…
Culmination of Four-Year Project With U.S. Department of Defense and NFL-GE Research Funding BETHESDA, Md.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/concussion?src=hash" target="_blank"gt;#concussionlt;/agt;–BrainScope®, a medical…
– Companies Plan to Submit Biologics License Application Later This Year – – Seattle Genetics to Hold Conference Call Today…
Leading venture capital firm Sofinnova Partners led the Series A financing, together with New Enterprise Associates, which co-led the round…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA) today announced that it will report results from its blinded, 40-week extension trial,…
— Statistically Significant Improvement Indicates Trofinetide’s Potential for Treating Rett Syndrome — Trofinetide for Rett Syndrome has Fast Track Status…
DUBLIN–(BUSINESS WIRE)–The “Stem Cell Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s offering.…
DUBLIN–(BUSINESS WIRE)–The “Next-Generation Sequencing (NGS) – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s offering.…
DUBLIN–(BUSINESS WIRE)–The “Global Psychiatry Partnering 2014-2019: Deal Trends, Players and Financials” report has been added to ResearchAndMarkets.com’s offering. Global Psychiatry…
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Humacyte, an innovator in biotechnology and regenerative medicine, announced publication in the medical journal Science Translational…